High Dose Valaciclovir As CMV Prophylaxis in Allogeneic Hematopoietic Stem Cell Recipients at High Risk of CMV Reactivation

被引：0
|
作者：
Douglas, Genevieve
Yong, Michelle K.
Tio, Shio Yen
Chau, Maggie
Sasadeusz, Joe
Slavin, Monica
Xie, Mingdi
Ritchie, David
Chee, Lynette C. Y.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-141764
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Effective CMV prophylaxis with high-dose valaciclovir in allogeneic hematopoietic stem-cell recipients at a high risk of CMV infection
    Douglas, Genevieve
    Yong, Michelle K.
    Tio, Shio Yen
    Chau, Maggie
    Prabahran, Ashvind
    Sasadeusz, Joe
    Slavin, Monica
    Ritchie, David
    Chee, Lynette
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (01)
  • [2] High Dose Valaciclovir as CMV Prophylaxis in Allogeneic Haematopoietic Stem Cell Transplantation
    Douglas, Genevieve
    Yong, Michelle
    Tio, Shioyen
    Chau, Maggie
    Sasadeusz, Joe
    Slavin, Monica
    Ritchie, David
    Chee, Lynette
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 489 - 490
  • [3] Neutrophils Response to Human CMV Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
    Costa, Martina
    Tamassia, Nicola
    Ligozzi, Marco
    Marini, Olivia
    Cassatella, Marco
    Tecchio, Cristina
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 479 - 479
  • [4] CMV REACTIVATION AFTER STOPPING LETERMOVIR PRIMARY PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS
    Chavaz, Lara
    Royston, Lena
    Masouridi-Levrat, Stavroula
    Mamez, Anne-Claire
    Giannotti, Federica
    Morin, Sarah
    Van Delden, Christian
    Chalandon, Yves
    Neofytos, Dionysios
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 93 - 93
  • [5] Risk for CMV Reactivation in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
    Qayed, Muna
    Khurana, Monica
    Hilinski, Joseph
    Gillespie, Scott
    McCracken, Courtney
    Applegate, Kristy
    Chiang, Kuang-Yueh
    Horan, John
    PEDIATRIC BLOOD & CANCER, 2015, 62 (02) : 364 - 366
  • [6] Incidence of cytomegalovirus (CMV) infection in allogeneic hematopoietic stem cell recipients at low risk of CMV infection
    Mori, T
    Okamoto, S
    Watanabe, R
    Yamazaki, R
    Tsukada, Y
    Nagayama, H
    Ishida, A
    Ikeda, Y
    BONE MARROW TRANSPLANTATION, 2002, 29 (12) : 1005 - 1006
  • [7] Incidence of cytomegalovirus (CMV) infection in allogeneic hematopoietic stem cell recipients at low risk of CMV infection
    T Mori
    S Okamoto
    R Watanabe
    R Yamazaki
    Y Tsukada
    H Nagayama
    A Ishida
    Y Ikeda
    Bone Marrow Transplantation, 2002, 29 : 1005 - 1006
  • [8] CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality
    Eberhardt, Kirsten Alexandra
    Jung, Verena
    Knops, Elena
    Heger, Eva
    Wirtz, Maike
    Steger, Gertrud
    Kaiser, Rolf
    Affeldt, Patrick
    Holtick, Udo
    Klein, Florian
    Scheid, Christof
    Di Cristanziano, Veronica
    BONE MARROW TRANSPLANTATION, 2023, 58 (06) : 639 - 646
  • [9] CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality
    Kirsten Alexandra Eberhardt
    Verena Jung
    Elena Knops
    Eva Heger
    Maike Wirtz
    Gertrud Steger
    Rolf Kaiser
    Patrick Affeldt
    Udo Holtick
    Florian Klein
    Christof Scheid
    Veronica Di Cristanziano
    Bone Marrow Transplantation, 2023, 58 : 639 - 646
  • [10] Incidence of CMV Reactivation and Infection in Children and Adolescents Following Allogeneic Hematopoietic Stem Cell Transplantation in High CMV Exposure Population
    Hussein, Ayad Ahmed
    Al-Antary, Eman T.
    Al-Zaben, Abdulhadi I.
    Frangoul, Haydar A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S253 - S253
12345